tetano
Editor, Senior Moderator
Clin Case Rep
. 2022 Feb 7;10(2):e05378.
doi: 10.1002/ccr3.5378. eCollection 2022 Feb.
Fulminant myocarditis after the second dose of COVID-19 mRNA vaccination
Akihiro Oka[SUP] 1 [/SUP], Yuya Sudo[SUP] 1 [/SUP], Toru Miyoshi[SUP] 2 [/SUP], Masatomo Ozaki[SUP] 1 [/SUP], Yuta Kimura[SUP] 1 [/SUP], Wataru Takagi[SUP] 1 [/SUP], Satoko Ugawa[SUP] 1 [/SUP], Tomoaki Okada[SUP] 1 [/SUP], Kazumasa Nosaka[SUP] 1 [/SUP], Masayuki Doi[SUP] 1 [/SUP]
Affiliations
Abstract
Myocarditis is an adverse event associated with coronavirus disease 2019 (COVID-19) mRNA vaccination. A 50-year-old man presented with dyspnea and resting chest pain after receiving the second dose of the COVID-19 mRNA vaccine and developed cardiogenic shock. Fulminant myocarditis was diagnosed by endomyocardial biopsy and treated with intravenous corticosteroids.
Keywords: COVID‐19 mRNA vaccination; fulminant myocarditis; steroid pulse therapy.
. 2022 Feb 7;10(2):e05378.
doi: 10.1002/ccr3.5378. eCollection 2022 Feb.
Fulminant myocarditis after the second dose of COVID-19 mRNA vaccination
Akihiro Oka[SUP] 1 [/SUP], Yuya Sudo[SUP] 1 [/SUP], Toru Miyoshi[SUP] 2 [/SUP], Masatomo Ozaki[SUP] 1 [/SUP], Yuta Kimura[SUP] 1 [/SUP], Wataru Takagi[SUP] 1 [/SUP], Satoko Ugawa[SUP] 1 [/SUP], Tomoaki Okada[SUP] 1 [/SUP], Kazumasa Nosaka[SUP] 1 [/SUP], Masayuki Doi[SUP] 1 [/SUP]
Affiliations
- PMID: 35154722
- PMCID: PMC8819635
- DOI: 10.1002/ccr3.5378
Abstract
Myocarditis is an adverse event associated with coronavirus disease 2019 (COVID-19) mRNA vaccination. A 50-year-old man presented with dyspnea and resting chest pain after receiving the second dose of the COVID-19 mRNA vaccine and developed cardiogenic shock. Fulminant myocarditis was diagnosed by endomyocardial biopsy and treated with intravenous corticosteroids.
Keywords: COVID‐19 mRNA vaccination; fulminant myocarditis; steroid pulse therapy.